| |
| |
|
| Insider
Information: |
Talbot George Harrison |
| Relationship: |
Director |
| City: |
Morristown |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
68,157 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$25,652 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
68,157 |
|
|
| Total
Value |
$25,652 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Durata Therapeutics, Inc. |
DRTX |
10% Owner |
2012-07-18 |
3,017 |
|
0 |
Premium* |
|
|
Nabriva Therapeutics AG |
NBRV |
Director |
2020-07-29 |
65,140 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NBRV |
Nabriva Therapeutics AG |
Director |
– • – |
2020-07-29 |
4 |
A |
$0.00 |
$0 |
D/D |
17,500 |
65,140 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Director |
– • – |
2018-07-31 |
4 |
B |
$2.75 |
$39,875 |
D/D |
14,500 |
47,640 |
2.39 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Director |
– • – |
2017-09-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,350 |
33,140 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Director |
– • – |
2017-06-19 |
4 |
S |
$91.00 |
$4,186 |
D/D |
(46) |
3,179 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Director |
– • – |
2017-06-16 |
4 |
S |
$93.50 |
$2,244 |
D/D |
(24) |
3,225 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Director |
– • – |
2017-06-15 |
4 |
S |
$94.10 |
$9,410 |
D/D |
(100) |
3,249 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Director |
– • – |
2017-05-30 |
4 |
S |
$101.00 |
$21,265 |
D/D |
(210) |
3,349 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Director |
– • – |
2017-05-25 |
4 |
S |
$100.50 |
$29,693 |
D/D |
(295) |
3,559 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Director |
– • – |
2017-05-23 |
4 |
S |
$99.70 |
$2,991 |
D/D |
(30) |
3,854 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Director |
– • – |
2017-05-16 |
4 |
S |
$102.27 |
$15,413 |
D/D |
(150) |
3,884 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Director |
– • – |
2017-05-15 |
4 |
S |
$101.50 |
$5,075 |
D/D |
(50) |
4,034 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Director |
– • – |
2017-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,235 |
4,084 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Director |
– • – |
2016-12-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,849 |
|
- |
|
| DRTX |
Durata Therapeutics, Inc. |
10% Owner |
– – • |
2012-07-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,017 |
|
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
